This country profile provides an overview of the Kingdom of Eswatini’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
13k people received treatment in Eswatini in 2019 393k people did not receive treatment in Eswatini in 2019
Eswatini does not require mass treatment for elephantiasis.
Eswatini does not require mass treatment for blinding trachoma.
Treatment coverage remained at 79% in 2018 and 2019.
Pre-sch and school-aged children needing treatment17k
Pre-school and school-aged children receiving treatment13k
Treatment coverage decreased from 95% in 2018 to 0% in 2019.
School-aged children needing treatment282k
School-aged children receiving treatmentZero
Eswatini does not require mass treatment for river blindness.
The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in eSwatini.